Pentixapharm Holding AG Thomas Maier

Language:EnglishDE

Pentixapharm Holding AG
Pentixapharm Holding AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
04.08.2026 / 16:20 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings
1. Details of issuer

Name:	Pentixapharm Holding AG
Street:	Robert-Rössle-Straße 10
Postal code:	13125
City:	Berlin Germany
Legal Entity Identifier (LEI):	3912005VBOVXNDXEQZ36

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
X	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligation

Natural person (first name, surname): Thomas Maier
Date of birth: 23 March 1967

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

Glycotope GmbH

5. Date on which threshold was crossed or reached:

30 Jul 2026

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	Total of both in % (7.a. + 7.b.)	Total number of voting rights pursuant to Sec. 41 WpHG
New	2.91 %	0 %	2.91 %	1,042,089
Previous notification	3.86 %	0 %	3.86 %	/

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)

ISIN	Absolute		In %
	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)
DE000A40AEG0	0	1,042,089	0 %	2.91 %
Total	1,042,089		2.91 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
			0	0 %
		Total	0	0 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
				0	0 %
			Total	0	0 %

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least 3% or more)	% of voting rights through instruments (if at least 5% or more)	Total of both (if at least 5% or more)
Thomas Maier	%	%	%
ATHOS KG	%	%	%
ATHOS Beteiligung GmbH	%	%	%
Santo Holding AG, Zug	%	%	%
Santo Holding (Deutschland) GmbH	%	%	%
Jossa Arznei GmbH	%	%	%
Santo Holding AG, Zug	%	%	%
Glycotope GmbH	2.91 %	%	%

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:

Proportion of voting rights	Proportion of instruments	Total of both
%	%	%

10. Other explanatory remarks:

Date

04 Aug 2026

04.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language:	English
Company:	Pentixapharm Holding AG
	Robert-Rössle-Straße 10
	13125 Berlin
	Germany
Internet:	https://www.pentixapharm.com/
LEI Code:	3912005VBOVXNDXEQZ36


End of News	EQS News Service

2377232 04.08.2026 CET/CEST